Clinical trial
13C-Spirulina Breath Test (13C-GEBT) Lot-to-Lot and Biological Variability Study
NCT04772261 is registered in ClinicalTrials.gov with Cairn Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 13C-Spirulina Breath Test (13C-GEBT) Lot-to-Lot and Biological Variability Study
- Lead sponsor
- Cairn Diagnostics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 5, 2021
- Completion date
- January 10, 2022
- Enrollment
- 21 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.